We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Grants Biovail Summary Judgment in Tiazac Cases
Court Grants Biovail Summary Judgment in Tiazac Cases
April 5, 2005
In a major win for Toronto-based biotechnology company Biovail, a U.S. district court has granted the company’s request for summary judgment in two related class-action lawsuits involving the company’s hypertension and angina medication, Tiazac.